加载中…
我们覆盖的 84 家公司，其中 78 家已评级
这里每家公司都经过同样的五项成长与现金创造检验。它描述的是这个行业今天申报出来的样子——而不是该买其中哪一家。
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | A | US$45.7B | US$39.19 | 65.32 | US$17.3B | 4.1% |
| HLN | Haleon plc | B+ | US$41.4B | US$9.26 | 18.87 | US$14.6B | 15.1% |
| TAK | Takeda Pharmaceutical Company Limited | B | US$30.3B | US$18.86 | 44.01 | US$28.7B | -3.4% |
| ZTS | Zoetis Inc. | A+ | US$29.4B | US$71.05 | 11.71 | US$9.5B | 27.5% |
| VTRS | VIATRIS INC. | C | US$20.5B | US$17.83 | — | US$14.7B | -23.9% |
| UTHR | United Therapeutics Corporation | B+ | US$20.4B | US$475.45 | 17.02 | US$3.2B | 41.6% |
| NBIX | NEUROCRINE BIOSCIENCES INC | A+ | US$14.1B | US$138.40 | 20.29 | US$3.4B | 20.9% |
| ELAN | Elanco Animal Health Incorporated | A | US$11.1B | US$22.31 | — | US$5B | -4.0% |
| RDY | DR. REDDY’S LABORATORIES LIMITED | B+ | US$10.2B | US$12.25 | 17.35 | US$3.5B | 12.8% |
| ALKS | Alkermes plc. | B | US$6.9B | US$40.85 | 107.50 | US$1.7B | 4.0% |
| HIMS | HIMS & HERS HEALTH, INC. | A- | US$6.8B | US$29.42 | — | US$2.6B | -5.5% |
| LNTH | Lantheus Holdings, Inc. | A+ | US$6.5B | US$99.74 | 24.15 | US$1.6B | 17.7% |
| AMRX | AMNEAL PHARMACEUTICALS, INC. | C | US$6.3B | US$19.77 | 40.35 | US$3.1B | 5.0% |
| KNSA | Kiniksa Pharmaceuticals International, plc | A | US$6.2B | US$75.08 | 82.51 | US$754M | 9.7% |
| LQDA | LIQUIDIA CORPORATION | A+ | US$6.1B | US$68.43 | 49.23 | US$450.9M | 30.7% |
| INDV | Indivior Pharmaceuticals, Inc. | D | US$4.2B | US$35.82 | 12.84 | US$1.3B | 26.7% |
| AMLX | Amylyx Pharmaceuticals, Inc. | D | US$3.3B | US$29.49 | — | US$0.00 | — |
| RGC | Regencell Bioscience Holdings Limited | 未评级 | US$3.1B | US$6.17 | — | — | — |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | C- | US$2.5B | US$42.66 | — | US$830.4M | -13.2% |
| HCM | HutchMED (China) LIMITED | D | US$2.4B | US$13.94 | 26.81 | US$549.1M | 3.3% |
| TRLV | TRULIEVE CANNABIS CORP. | D | US$2.4B | US$12.21 | — | US$1.1B | -41.8% |
| PBH | PRESTIGE CONSUMER HEALTHCARE INC. | C+ | US$2.2B | US$46.61 | 13.06 | US$1.1B | 15.6% |
| BCRX | BIOCRYST PHARMACEUTICALS, INC. | A | US$2.2B | US$8.59 | — | US$940.6M | -40.9% |
| PRGO | Perrigo Company plc | F- | US$2.1B | US$15.42 | — | US$4.1B | -41.9% |
| BHC | Bausch Health Companies Inc. | A | US$2.1B | US$5.69 | — | US$10.9B | -10.1% |
| ALVO | ALVOTECH | B | US$1.8B | US$5.75 | 57.50 | US$586.3M | 4.8% |
| XERS | XERIS BIOPHARMA HOLDINGS, INC. | F- | US$1.7B | US$9.10 | — | US$335.4M | -5.1% |
| ETON | Eton Pharmaceuticals, Inc. | A+ | US$1.6B | US$57.68 | — | US$105.6M | 12.0% |
| ANIP | ANI PHARMACEUTICALS, INC | A+ | US$1.6B | US$74.00 | 15.98 | US$978.4M | 11.1% |
| PAHC | Phibro Animal Health Corporation | B | US$1.4B | US$34.45 | 14.12 | US$1.5B | 6.6% |
| HROW | Harrow, Inc. | B- | US$1.2B | US$33.07 | — | US$275.6M | -13.5% |
| CRON | CRONOS GROUP INC. | A | US$1.2B | US$3.34 | 16.70 | US$179.1M | 39.1% |
| AMPH | Amphastar Pharmaceuticals, Inc. | A+ | US$1.1B | US$26.13 | 15.46 | US$730M | 10.8% |
| PCRX | PACIRA BIOSCIENCES, INC. | A | US$1B | US$25.12 | 71.77 | US$746.2M | 2.0% |
| COLL | Collegium Pharmaceutical, Inc. | A+ | US$733.5M | US$22.53 | 18.17 | US$808.2M | 5.9% |
| IRWD | IRONWOOD PHARMACEUTICALS, INC. | C+ | US$682.4M | US$4.13 | 5.36 | US$389.3M | 33.4% |
| AQST | Aquestive Therapeutics, Inc. | C | US$587.4M | US$4.68 | — | US$54.1M | -144.6% |
| TLRY | Tilray Brands, Inc. | C- | US$562.5M | US$4.13 | — | US$915.5M | -13.3% |
| GLAS | Glass House Brands Inc. | D- | US$557.2M | US$6.80 | — | US$152.9M | -33.7% |
| EOLS | EVOLUS, INC. | B | US$526.4M | US$7.97 | — | US$316.5M | -10.8% |
| KMDA | KAMADA LTD | C | US$503M | US$8.72 | 22.95 | US$191.8M | 11.6% |
| TKNO | ALPHA TEKNOVA, INC. | B- | US$500.9M | US$9.33 | — | US$43.7M | -38.4% |
| CGC | Canopy Growth Corp | D- | US$398.3M | US$0.94 | — | US$207.3M | -79.2% |
| EBS | EMERGENT BIOSOLUTIONS INC. | C | US$348.1M | US$6.79 | — | US$770.2M | -23.0% |
| BIOA | BIOAGE LABS, INC. | D- | US$323.6M | US$7.05 | — | US$10.4M | -912.3% |
| INCR | INTERCURE LTD. | C- | US$284.9M | US$5.21 | — | US$88.2M | -13.2% |
| EVO | Evotec SE | D- | US$277.3M | US$1.56 | — | US$897M | -13.1% |
| ANIK | Anika Therapeutics, Inc. | B- | US$272.6M | US$20.37 | — | US$120.7M | -3.1% |
| AKBA | AKEBIA THERAPEUTICS, INC. | C | US$248.3M | US$0.90 | — | US$219.1M | -13.5% |
| SIGA | Siga Technologies INC | F- | US$247.9M | US$3.45 | — | US$53.7M | -5.2% |
| ACB | AURORA CANNABIS INC | D | US$230.6M | US$4.10 | 145.20 | US$226.3M | -42.4% |
| ORGO | ORGANOGENESIS HOLDINGS INC. | B- | US$181.4M | US$1.41 | — | US$457.5M | -18.4% |
| CRDL | Cardiol Therapeutics Inc. | 未评级 | US$171.4M | US$1.71 | — | — | — |
| DERM | Journey Medical Corp | C- | US$168.2M | US$6.14 | — | US$68.2M | -9.0% |
| ADCT | ADC Therapeutics SA | D | US$162.1M | US$1.27 | — | US$79.6M | -121.8% |
| LFCR | LIFECORE BIOMEDICAL, INC. | D | US$159M | US$4.20 | — | US$128.9M | -30.0% |
| CPIX | Cumberland Pharmaceuticals Inc. | F- | US$114M | US$7.61 | — | US$39.9M | -27.4% |
| OGI | ORGANIGRAM HOLDINGS INC. | C- | US$104.8M | US$1.10 | — | US$183M | -9.6% |
| CTOR | Citius Oncology, Inc. | 未评级 | US$97.6M | US$1.05 | — | — | — |
| ZYBT | Zhengye Biotechnology Holding Limited | D | US$61.8M | US$1.31 | 35.03 | US$17.3M | -60.0% |
| SCYX | SCYNEXIS, Inc. | F- | US$43.7M | US$4.39 | 15.14 | US$19.2M | -53.3% |
| IMCC | IM Cannabis Corp. | C | US$36.4M | US$2.84 | — | US$32.3M | -39.1% |
| RMTI | ROCKWELL MEDICAL, INC. | B- | US$33.7M | US$8.37 | — | US$69.4M | -7.3% |
| CPHI | CHINA PHARMA HOLDINGS, INC. | C- | US$32.3M | US$0.75 | — | US$3.9M | -114.3% |
| BGM | BGM Group Ltd | F- | US$27.2M | US$0.24 | — | US$37.9M | -52.6% |
| AYTU | AYTU BIOPHARMA, INC | C | US$24.8M | US$2.28 | — | US$57.6M | -24.8% |
| TXMD | TherapeuticsMD, Inc. | F- | US$23.7M | US$2.05 | — | US$3.3M | -6.6% |
| RDHL | REDHILL BIOPHARMA LTD. | F- | US$22.5M | US$0.50 | — | US$286K | -150.0% |
| BFRI | Biofrontera Inc. | B- | US$17.5M | US$1.18 | — | US$46.2M | -13.8% |
| TLPH | TALPHERA, INC. | C- | US$16.8M | US$1.18 | — | US$1K | -1,507,600.0% |
| CABR | CARING BRANDS, INC. | F- | US$12.8M | US$1.24 | — | US$4.2K | -183,255.2% |
| APUS | APIMEDS PHARMACEUTICALS US, INC. | 未评级 | US$10.9M | US$7.25 | — | — | — |
| INM | INMED PHARMACEUTICALS INC. | D- | US$7.6M | US$1.38 | — | US$4.5M | -278.7% |
| SNOA | SONOMA PHARMACEUTICALS, INC. | B- | US$6.1M | US$1.27 | — | US$21.9M | -10.3% |
| GELS | Gelteq Limited | D- | US$5.2M | US$0.55 | — | US$116.3K | -4,011.9% |
| SBFM | Sunshine Biopharma Inc. | C- | US$3.3M | US$0.84 | — | US$35.3M | -16.5% |
| SHPH | SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | 未评级 | US$3M | US$4.01 | — | — | — |
| UPC | Universe Pharmaceuticals INC | D- | US$2.7M | US$4.75 | — | US$17.9B | -20.6% |
| SXTC | China SXT Pharmaceuticals, Inc. | F- | US$2.5M | US$2.57 | — | US$1.1M | -545.2% |
| YCBD | cbdMD, Inc. | D- | US$1.9M | US$0.47 | — | US$20.9M | -13.8% |
| IXHL | Incannex Healthcare Inc. | F- | US$1.7M | US$3.32 | — | US$0.00 | — |
| PRFX | PRF Technologies Ltd. | B- | US$811.3K | US$0.98 | — | US$17K | -29,541.2% |
| AKAN | AKANDA CORP. | F | US$210.3K | US$3.05 | 0.24 | US$258.1K | -17,690.2% |
| OPTH | Optimi Health Corp. | 未评级 | — | US$4.82 | — | — | — |
基本面来自 SEC 申报文件，价格来自最近一次行情更新。可按任意列排序；没有数值的公司在两个方向都排在末尾。
按市值从大到小排序；点击任意列可重新排序。没有数值的公司在两个方向都排在末尾，因为市盈率缺失意味着亏损，而不是便宜。这里没有任何内容构成推荐。